Imago understands media’s importance to bringing its Visual Intelligence story to a global audience. Imago wishes to tell its story beyond the obvious medical imaging marketplace. We believe Imago’s Visual Intelligence story is relevant to consumers in general, the financial community, technology and equipment manufacturers, pet owners, doctors, medical research and development professionals, insurance companies, hospitals and clinics or any industry that uses digital imagery as a measure of information.
We’ve arranged our media section to provide access to Imago messaging, video and photo archives, press releases, relevant news, management bios and photos, and various white papers.
Thank you for your help
MedAxiom / Imago Systems press release from Imago
MedAxiom, an ACC (American College of Cardiology) Company dedicated to cardiovascular organization p...
MedAxiom Announces Industry Partnership with Imago Systems
IMAGO SYSTEMS IMPROVES CLINICAL DIAGNOSTICS THROUGH ENHANCED IMAGING SOFTWARE Partner News |...
Imago Systems Completes $2.5 million SAFE Equity Raise
Imago Systems has completed a $2.5 million SAFE equity raise. It is now moving forward on a Series B...
Imago Systems Submits Q-sub to FDA under Direction of Imago Board Member, Dr. Susan Alpert, M.D., Ph.D., for Its ICE Insight™ Software System (Imago ICE Insight™) for Cardiovascular Image Post-processing
Pursuant to Regulation 21 CFR § 892.2050, Imago Systems has developed a medical image enhancement s...
Additional Imago Systems Patents Granted
Imago Systems, Inc., has extended its IP protection for its Visual Intelligence™ (VI) technology, ...
Imago Systems, Inc., and Acculab Life Sciences, LLC, Announce Three-year Research Agreement in Cardiovascular Medicine
Imago Systems and Acculab Life Sciences have announced a three-year research agreement in cardiovasc...
Thomas Ramsay, Imago Systems CEO, featured speaker at 2023 LSI Emerging Medtech Summit in Dana Point, California.
Presentation: Imago is pioneering the development of Visual Intelligence (VI)™, a novel image anal...
Imago Systems Selected as Innovator at LSI Emerging Medtech Summit Conference in California.
Peter McBride, Imago’s Executive Director of Cardiovascular Medicine, and Tom Ramsay, Imago’s CE...
Imago Systems’ Visual Intelligence Positioned to Address Latest FDA Warnings about Dense Breast Cancer Detection
The U.S. Preventive Services Task Force (USPSTF) has released new draft recommendations for breast c...
FDA Updates Mammography Regulations to Require Reporting of Breast Density Information and Enhance Facility Oversight
Today, the U.S. Food and Drug Administration published updates to the mammography regulations to, am...
Michael McGarry Joins Imago Systems as Chief Growth Officer
Michael McGarry, MBA, joined Imago on March 1 as the Company’s Chief Growth Officer. Michael i...
Nancy Goetzinger Assumes Position of Director of Breast Imaging – Leads Product Introduction Effort with Latam Partners in Argentina
Nancy Goetzinger’s role at Imago has expanded from Director of Training for Imago ICE Reveal™, t...
Imago Systems, Inc., Receives Clearance to Work with WCG for Acquiring Independent IRB)Assessments Faster
Imago Systems, Inc., received clearance to work with WCG* for acquiring independent institutional re...
Imago Systems Selected to Present at Transcatheter Cardiovascular Therapeutics (TCT) Conference in Boston, MA
Imago’s clinical advisor, Dr. Sanjay Bhojraj, and CEO Thomas Ramsay (a TCT faculty member) present...
New study confirms higher cancer rate in women with dense breast tissue
Read full article here....
Imago Systems Announces Collaboration with Mayo Clinic for Breast Imaging
Mayo Clinic to Support Clinical Trial Development and Oversee Imago’s Reader Studies for Mammograp...
Imago Systems Awarded NIH/NCI Contract for Novel Diagnostic Imaging for Cancer Immunotherapies
Lansdowne, VA – October 9, 2018 – Imago Systems, an innovator in image visualization and artific...